A team of Chinese scientists has grown the heart's natural pacemaker in a laboratory dish, raising the possibility that patients with faulty heart rhythms could one day receive a biological replacement instead of an electronic device.
Researchers at the Guangzhou Institutes of Biomedicine and Health, part of the Chinese Academy of Sciences, created the sinoatrial node, a cluster of cells that sets the heart's rhythm, using stem cells. The sinoatrial node is sometimes called the heart's master conductor because it generates the electrical impulses that tell the heart when to beat.
A tiny cluster of cells that keeps the beat
The sinoatrial node is a small structure located in the right upper chamber of the heart. When it fails, the heart can beat too slowly, too quickly, or irregularly. Millions of people worldwide rely on electronic pacemakers to correct these problems. But pacemakers have drawbacks. They require surgery to implant, batteries that need replacing, and they can be vulnerable to infection or interference.
The Guangzhou team wanted to see if they could build a biological alternative. They started with human stem cells and guided them through a series of chemical steps to become sinoatrial node cells. The process took about 26 days. At the end, the cells were beating spontaneously, just like the real thing.
Why this matters for people with heart disease
The scientists then tested the lab grown tissue in rats. They implanted the cells into the hearts of rats whose own sinoatrial nodes had been disabled. The transplanted cells integrated with the rat heart tissue and began driving the heartbeat. The animals' hearts resumed a normal rhythm.
For local communities in China, where heart disease is a leading cause of death, the prospect of a biological pacemaker is significant. Electronic pacemakers are effective but expensive and require lifelong maintenance. A living patch of cells that could be implanted once and last a lifetime would be a major advance. The research is still early, and human trials are likely years away. But the work shows that building a replacement for the heart's master conductor is no longer science fiction.
A step toward regenerative medicine
The study, published in the journal Cell Stem Cell, is part of a broader push in China to develop regenerative therapies for organ failure. The country has invested heavily in stem cell research and clinical applications. If this approach proves safe and effective in humans, it could change how doctors treat arrhythmias, the irregular heartbeats that affect tens of millions of people globally.
The Guangzhou team is now working to scale up production of the sinoatrial node cells and test them in larger animals. They also need to ensure the cells do not turn into tumors or trigger immune rejection. Those are hurdles that every stem cell therapy must clear. But the fact that a biological pacemaker has been grown and tested in a living animal is a milestone that brings the idea closer to the clinic.
